A:During the last week of July, the U.S. Food and Drug Administration has approved the drug Colcrys to treat acute flairs in patients with gout. The medication’s active ingredient is colchicine, which has been used by healthcare practitioners for many years to treat gout but had not been approved by the FDA. For more information see this web site.
